Orbsen Therapeutics Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Private

  • Employees
  • 12

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Financing Rounds
  • 7

Orbsen Therapeutics General Information

Description

Operator of a regenerative medicine company intended to promote the healing, repair, and regeneration of damaged tissues. The company develops ground-breaking stromal cell treatments to address heart disease, arterial disease of the limbs, diabetes complications, arthritis, and other inflammatory conditions, enabling patients to get cured of rare medical syndromes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • Orbsen Building, NUIG
  • University Road
  • Galway H91 TK33
  • Ireland
+353 (091)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Orbsen Building, NUIG
  • University Road
  • Galway H91 TK33
  • Ireland
+353 (091)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Orbsen Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Orbsen Therapeutics‘s full profile, request access.

Request a free trial

Orbsen Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a regenerative medicine company intended to promote the healing, repair, and regeneration of damaged tissues
Drug Discovery
Galway, Ireland
12 As of 2015

Rockville, MD
 

Plymouth Meeting, PA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Orbsen Therapeutics Competitors (109)

One of Orbsen Therapeutics’s 109 competitors is Regenerx, a Formerly VC-backed company based in Rockville, MD.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Regenerx Formerly VC-backed Rockville, MD
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA
Verona Pharma Corporate Backed or Acquired London, United Kingdom
AlgoTx Venture Capital-Backed Suresnes, France
Orchard Therapeutics Formerly VC-backed London, United Kingdom
You’re viewing 5 of 109 competitors. Get the full list »

Orbsen Therapeutics Patents

Orbsen Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260335374-A1 Compositions and methods for treating kidney disease Pending 13-Oct-2022
AU-2023361649-A1 Scd2+ stromal cells for treating diabetic kidney disease Pending 13-Oct-2022
EP-4601661-A1 Scd2+ stromal cells for treating diabetic kidney disease Pending 13-Oct-2022
WO-2024079524-A1 Scd2+ stromal cells for treating diabetic kidney disease Inactive 13-Oct-2022
EP-4017512-A1 Compositions for monocyte and macrophage polarization and methods of use Active 23-Aug-2019 A61K35/28
To view Orbsen Therapeutics’s complete patent history, request access »

Orbsen Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Orbsen Therapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Orbsen Therapeutics‘s full profile, request access.

Request a free trial

Orbsen Therapeutics FAQs

  • When was Orbsen Therapeutics founded?

    Orbsen Therapeutics was founded in 2006.

  • Where is Orbsen Therapeutics headquartered?

    Orbsen Therapeutics is headquartered in Galway, Ireland.

  • What is the size of Orbsen Therapeutics?

    Orbsen Therapeutics has 12 total employees.

  • What industry is Orbsen Therapeutics in?

    Orbsen Therapeutics’s primary industry is Drug Discovery.

  • Is Orbsen Therapeutics a private or public company?

    Orbsen Therapeutics is a Private company.

  • What is Orbsen Therapeutics’s current revenue?

    The current revenue for Orbsen Therapeutics is .

  • How much funding has Orbsen Therapeutics raised over time?

    Orbsen Therapeutics has raised $3.9M.

  • Who are Orbsen Therapeutics’s investors?

    Horizon 2020 and The BioHub Birmingham have invested in Orbsen Therapeutics.

  • Who are Orbsen Therapeutics’s competitors?

    Regenerx, Inovio Pharmaceuticals, Verona Pharma, AlgoTx, and Orchard Therapeutics are some of the 109 competitors of Orbsen Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process